CH585746A5 - - Google Patents
Info
- Publication number
- CH585746A5 CH585746A5 CH718776A CH718776A CH585746A5 CH 585746 A5 CH585746 A5 CH 585746A5 CH 718776 A CH718776 A CH 718776A CH 718776 A CH718776 A CH 718776A CH 585746 A5 CH585746 A5 CH 585746A5
- Authority
- CH
- Switzerland
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D337/00—Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
- C07D337/02—Seven-membered rings
- C07D337/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D337/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D337/14—[b,f]-condensed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
- C07D313/02—Seven-membered rings
- C07D313/06—Seven-membered rings condensed with carbocyclic rings or ring systems
- C07D313/10—Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
- C07D313/14—[b,f]-condensed
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Epidemiology (AREA)
- Anesthesiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrane Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Priority Applications (26)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH835473A CH585745A5 (fr) | 1973-06-08 | 1973-06-08 | |
CH718776A CH585746A5 (fr) | 1973-06-08 | 1973-06-08 | |
CH718876A CH585747A5 (fr) | 1973-06-08 | 1973-06-08 | |
AU69362/74A AU486305B2 (en) | 1973-06-08 | 1974-05-24 | DIBENZO (b, f) THIE PINES AND DIBENZO (b, f) OXEPINES |
DE2426040A DE2426040C2 (de) | 1973-06-08 | 1974-05-30 | Dibenzo[b,f]oxepin-oder-thiepinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Präparate |
CA201,871A CA1030545A (fr) | 1973-06-08 | 1974-06-06 | Dibenzo (b,f) thiepines et dibenzo (b,f) oxepines substitues en propynylamine |
BE145116A BE815967A (fr) | 1973-06-08 | 1974-06-06 | Composes tricycliques |
LU70255A LU70255A1 (fr) | 1973-06-08 | 1974-06-06 | |
FR7419507A FR2232309B1 (fr) | 1973-06-08 | 1974-06-06 | |
GB1321476A GB1449299A (en) | 1973-06-08 | 1974-06-07 | Tricyclic compounds |
GB2538174A GB1449297A (en) | 1973-06-08 | 1974-06-07 | Tricyclic compounds |
AT474574A AT339318B (de) | 1973-06-08 | 1974-06-07 | Verfahren zur herstellung von neuen tricyclischen verbindungen und ihren n-oxiden und salzen |
JP49064159A JPS6020392B2 (ja) | 1973-06-08 | 1974-06-07 | ジベンゾチエピン誘導体の製造方法 |
NL7407672A NL7407672A (fr) | 1973-06-08 | 1974-06-07 | |
GB1321576A GB1449300A (en) | 1973-06-08 | 1974-06-07 | Tricyclic compounds |
US500770A US3928383A (en) | 1973-06-08 | 1974-08-26 | Propynylamine-substituted dibenzo{8 b,f{9 thiepins and dibenz{8 b,f{9 oxepins |
US05/613,680 US4005105A (en) | 1973-06-08 | 1975-09-15 | Substituted 10-ethynyldibenzo[b,f]thiepins and dibenz[b,f]oxepins |
GB1321376*[A GB1449298A (en) | 1973-06-08 | 1976-06-07 | Tricyclic compounds |
US05/714,166 US4035385A (en) | 1973-06-08 | 1976-08-13 | Substituted dibenzo [b,f]thiepins and dibenz[b,f]oxepins |
US05/714,165 US4035386A (en) | 1973-06-08 | 1976-08-13 | Propynylamine-substituted dibenzo[b,f]thiepins and dibenz[b,f]oxepins |
AT623276A AT340439B (de) | 1973-06-08 | 1976-08-23 | Verfahren zur herstellung von neuen tricyclischen verbindungen und ihren n-oxiden und salzen |
AT623376A AT340440B (de) | 1973-06-08 | 1976-08-23 | Verfahren zur herstellung von neuen tricyclischen verbindungen und ihren n-oxiden und salzen |
CA291,666A CA1038874A (fr) | 1973-06-08 | 1977-11-24 | Composes tricycliques |
CA291,667A CA1043342A (fr) | 1973-06-08 | 1977-11-24 | Composes tricycliques |
CA291,668A CA1038875A (fr) | 1973-06-08 | 1977-11-24 | Composes tricycliques |
JP57057457A JPS6029715B2 (ja) | 1973-06-08 | 1982-04-08 | 三環式化合物の製造方法 |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH718876A CH585747A5 (fr) | 1973-06-08 | 1973-06-08 | |
CH718776A CH585746A5 (fr) | 1973-06-08 | 1973-06-08 | |
CH835473A CH585745A5 (fr) | 1973-06-08 | 1973-06-08 |
Publications (1)
Publication Number | Publication Date |
---|---|
CH585746A5 true CH585746A5 (fr) | 1977-03-15 |
Family
ID=27175724
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH718776A CH585746A5 (fr) | 1973-06-08 | 1973-06-08 | |
CH718876A CH585747A5 (fr) | 1973-06-08 | 1973-06-08 | |
CH835473A CH585745A5 (fr) | 1973-06-08 | 1973-06-08 |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CH718876A CH585747A5 (fr) | 1973-06-08 | 1973-06-08 | |
CH835473A CH585745A5 (fr) | 1973-06-08 | 1973-06-08 |
Country Status (10)
Country | Link |
---|---|
JP (2) | JPS6020392B2 (fr) |
AT (1) | AT339318B (fr) |
BE (1) | BE815967A (fr) |
CA (1) | CA1030545A (fr) |
CH (3) | CH585746A5 (fr) |
DE (1) | DE2426040C2 (fr) |
FR (1) | FR2232309B1 (fr) |
GB (4) | GB1449297A (fr) |
LU (1) | LU70255A1 (fr) |
NL (1) | NL7407672A (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997045422A1 (fr) * | 1996-05-30 | 1997-12-04 | Novartis Ag | SELS DE 10-AMINOALIPHATHYL-DIBENZ[b,f] OXEPINES A ACTION ANTI-NEURODEGENERATIVE |
-
1973
- 1973-06-08 CH CH718776A patent/CH585746A5/xx not_active IP Right Cessation
- 1973-06-08 CH CH718876A patent/CH585747A5/xx not_active IP Right Cessation
- 1973-06-08 CH CH835473A patent/CH585745A5/xx not_active IP Right Cessation
-
1974
- 1974-05-30 DE DE2426040A patent/DE2426040C2/de not_active Expired
- 1974-06-06 LU LU70255A patent/LU70255A1/xx unknown
- 1974-06-06 FR FR7419507A patent/FR2232309B1/fr not_active Expired
- 1974-06-06 BE BE145116A patent/BE815967A/fr unknown
- 1974-06-06 CA CA201,871A patent/CA1030545A/fr not_active Expired
- 1974-06-07 GB GB2538174A patent/GB1449297A/en not_active Expired
- 1974-06-07 JP JP49064159A patent/JPS6020392B2/ja not_active Expired
- 1974-06-07 GB GB1321476A patent/GB1449299A/en not_active Expired
- 1974-06-07 GB GB1321576A patent/GB1449300A/en not_active Expired
- 1974-06-07 AT AT474574A patent/AT339318B/de not_active IP Right Cessation
- 1974-06-07 NL NL7407672A patent/NL7407672A/xx not_active Application Discontinuation
-
1976
- 1976-06-07 GB GB1321376*[A patent/GB1449298A/en not_active Expired
-
1982
- 1982-04-08 JP JP57057457A patent/JPS6029715B2/ja not_active Expired
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1997045422A1 (fr) * | 1996-05-30 | 1997-12-04 | Novartis Ag | SELS DE 10-AMINOALIPHATHYL-DIBENZ[b,f] OXEPINES A ACTION ANTI-NEURODEGENERATIVE |
Also Published As
Publication number | Publication date |
---|---|
DE2426040C2 (de) | 1983-01-27 |
GB1449299A (en) | 1976-09-15 |
BE815967A (fr) | 1974-12-06 |
GB1449300A (en) | 1976-09-15 |
LU70255A1 (fr) | 1976-04-13 |
AT339318B (de) | 1977-10-10 |
CH585745A5 (fr) | 1977-03-15 |
CH585747A5 (fr) | 1977-03-15 |
JPS5035182A (fr) | 1975-04-03 |
AU6936274A (en) | 1975-11-27 |
ATA474574A (de) | 1977-02-15 |
GB1449297A (en) | 1976-09-15 |
GB1449298A (en) | 1976-09-15 |
FR2232309B1 (fr) | 1977-03-11 |
JPS5823684A (ja) | 1983-02-12 |
JPS6029715B2 (ja) | 1985-07-12 |
DE2426040A1 (de) | 1975-01-02 |
JPS6020392B2 (ja) | 1985-05-21 |
CA1030545A (fr) | 1978-05-02 |
FR2232309A1 (fr) | 1975-01-03 |
NL7407672A (fr) | 1974-12-10 |
Similar Documents
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PL | Patent ceased |